Sponsor or institution

Clinical trials and research at Cullgen (Shanghai),Inc

• 2Clinical trials
• 1Country

All recruiting trials (2)

• CG001419 tablets for adults with advanced solid tumors that have NTRK gene changes.

  This will test whether the oral drug CG001419 is safe and can control advanced or metastatic solid tumors in adults whose cancers have NTRK fusions, mutations, or amplifications.

  Recruiting at 6 sites Phase 1/2 Cullgen (Shanghai),Inc · Beijing and 5 other locations · NCT07394374

• CG009301 for adults with relapsed or treatment‑resistant blood cancers

  This trial will try a new drug called CG009301 to see if it's safe and helps adults whose leukemia or related blood cancers have come back or not responded to prior treatment.

  Recruiting at 3 sites Phase 1 Cullgen (Shanghai),Inc · Nanchang and 2 other locations · NCT07347171

Quick answers

How many clinical trials run by Cullgen (Shanghai),Inc are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →